Frederick Campbell
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery 4
- Molecular Biology top 10%
- RNA Interference and Gene Delivery 16
- Advanced biosensing and bioanalysis techniques 12
- Lipid Membrane Structure and Behavior 8
- Pharmaceutical Science top 10%
-
- Zebrafish Biomedical Research Applications 4
-
- Virus-based gene therapy research 5
-
- Nanoplatforms for cancer theranostics 3
-
- Click Chemistry and Applications 2
- Co-authors
- Alexander KrosJeroen BussmannLi KongGabriela Arias‐AlpizarJörg HuwylerSandro SieberDominik WitzigmannFrank L. Bos
- Journals
- Biomaterials Science (3 papers)Molecular Pharmaceutics (2 papers)Advanced Healthcare Materials (2 papers)
- Partner nations
- NetherlandsUnited KingdomUnited States
In The Last Decade
Frederick Campbell
32 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Biomaterials 288
- Molecular Biology 785
- Pharmaceutical Science 40
- Cell Biology 104
- Immunology 129
Countries citing papers authored by Frederick Campbell
This map shows the geographic impact of Frederick Campbell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick Campbell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick Campbell more than expected).
Fields of papers citing papers by Frederick Campbell
This network shows the impact of papers produced by Frederick Campbell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick Campbell. The network helps show where Frederick Campbell may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Frederick Campbell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2023 | 3 | |
| 3 | 2023 | 6 | |
| 4 | Anionic Lipid Nanoparticles Preferentially Deliver mRNA to the Hepatic Reticuloendothelial Systembreakdown → | 2022 | 144 |
| 5 | 2021 | 11 | |
| 6 | 2021 | 2 | |
| 7 | 2020 | 76 | |
| 8 | 2020 | 9 | |
| 9 | 2019 | 122 | |
| 10 | 2018 | 17 | |
| 11 | 2017 | 5 | |
| 12 | 2016 | 14 | |
| 13 | 2015 | 118 | |
| 14 | 2014 | 29 | |
| 15 | 2013 | 44 | |
| 16 | 2012 | 23 | |
| 17 | 2011 | 11 | |
| 18 | 2010 | 69 | |
| 19 | 1994 | 7 | |
| 20 | 1987 | 2 |
About Frederick Campbell
Frederick Campbell is a scholar working on Biomaterials, Molecular Biology and Software, having authored 32 papers that have together received 1.3k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (16 papers), Advanced biosensing and bioanalysis techniques (12 papers), Lipid Membrane Structure and Behavior (8 papers), Virus-based gene therapy research (5 papers), Nanoparticle-Based Drug Delivery (4 papers), Zebrafish Biomedical Research Applications (4 papers), Nanoplatforms for cancer theranostics (3 papers) and Click Chemistry and Applications (2 papers). The work is most often cited by research in Biomaterials (288 citations), Molecular Biology (785 citations) and Pharmaceutical Science (40 citations). Frederick Campbell has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include Alexander Kros, Jeroen Bussmann, Li Kong, Gabriela Arias‐Alpizar, Jörg Huwyler, Sandro Sieber, Dominik Witzigmann, Frank L. Bos, Sylvestre Bonnet and Bjørn E. V. Koch. Their work appears in journals such as Biomaterials Science, Molecular Pharmaceutics, Advanced Healthcare Materials, Organic & Biomolecular Chemistry and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.